(Q42954882)

English

Coelomycin, a highly substituted 2,6-dioxo-pyrazine fungal metabolite antibacterial agent discovered by Staphylococcus aureus fitness test profiling

scientific article published on July 28, 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Coelomycin, a highly substituted 2,6-dioxo-pyrazine fungal metabolite antibacterial agent discovered by Staphylococcus aureus fitness test profiling (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Staphylococcus aureus

1 reference

based on heuristic

inferred from title

6

object named as

Gerald F. Bills

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20664605

11 June 2024

author name string

Chaowei Zhang

2

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Marta Arocho

4

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Francisca Vicente

5

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Jon Polishook

7

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Karen Dorso

8

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Russell Onishi

9

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Charles Gill

10

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Emily Hickey

11

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Suzy Lee

12

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Richard Ball

13

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Stephen Skwish

14

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Michael A. Goetz

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20664605

11 June 2024

Deborah L. Zink

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20664605

11 June 2024

Robert G. K. Donald

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20664605

11 June 2024

John W. Phillips

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20664605

11 June 2024

Sheo B. Singh

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20664605

11 June 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20664605

11 June 2024

publication date

28 July 2010

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

full work available at URL

https://www.nature.com/articles/ja201086.pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20664605

11 June 2024

http://www.nature.com/articles/ja201086.pdf

Portable Document Format

1 reference

10.1038/JA.2010.86

https://api.crossref.org/works/10.1038/JA.2010.86

11 June 2024

http://www.nature.com/articles/ja201086

1 reference

10.1038/JA.2010.86

https://api.crossref.org/works/10.1038/JA.2010.86

11 June 2024

The Journal of Antibiotics

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

63

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

512-518

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

https://scigraph.springernature.com/pub.10.1038/ja.2010.86

0 references

Invasive methicillin-resistant Staphylococcus aureus infections in the United States

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.86

21 January 2018

Empirical antibacterial drug discovery--foundation in natural products

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.86

21 January 2018

Enhancement of antibiotic and secondary metabolite detection from filamentous fungi by growth on nutritional arrays

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.86

21 January 2018

Discovery of lucensimycins A and B from Streptomyces lucensis MA7349 using an antisense strategy

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.86

21 January 2018

Isolation, structure, and antibacterial activities of lucensimycins D-G, discovered from Streptomyces lucensis MA7349 using an antisense strategy

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.86

21 January 2018

Platensimycin is a selective FabF inhibitor with potent antibiotic properties

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.86

21 January 2018

Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.86

21 January 2018

Discovery of FabH/FabF inhibitors from natural products

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.86

21 January 2018

Discovery of bacterial fatty acid synthase inhibitors from a Phoma species as antimicrobial agents using a new antisense-based strategy.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.86

21 January 2018

Determination of selectivity and efficacy of fatty acid synthesis inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.86

21 January 2018

Chemical genetic identification of peptidoglycan inhibitors potentiating carbapenem activity against methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.86

21 January 2018

PAP inhibitor with in vivo efficacy identified by Candida albicans genetic profiling of natural products.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.86

21 January 2018

Isolation and structure elucidation of parnafungins, antifungal natural products that inhibit mRNA polyadenylation.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.86

21 January 2018

Isolation, structure and biological activity of phomafungin, a cyclic lipodepsipeptide from a widespread tropical Phoma sp.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.86

21 January 2018

Isolation, structure elucidation, and biological activity of virgineone from Lachnum Wirgineum using the genome-wide Candida albicans fitness test

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.86

21 January 2018

Genome-wide fitness test and mechanism-of-action studies of inhibitory compounds in Candida albicans

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.86

21 January 2018

Synthesis of natural flutimide and analogous fully substituted pyrazine-2,6-diones, endonuclease inhibitors of influenza virus

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.86

21 January 2018

A new 1-hydroxy-2,6-pyrazinedione associated with hypovirulent isolates of Sclerotinia minor

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.86

21 January 2018

Bioactive compounds from the seed fungus Menisporopsis theobromae BCC 3975.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.86

21 January 2018

Phase annealing in SHELX-90: direct methods for larger structures

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.86

21 January 2018

A short history of SHELX

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.86

21 January 2018

Antibacterial agents that inhibit lipid A biosynthesis.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.86

21 January 2018

Discovery of a small molecule that inhibits cell division by blocking FtsZ, a novel therapeutic target of antibiotics

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.86

21 January 2018

Antibacterial evaluations of thiazomycin- a potent thiazolyl peptide antibiotic from Amycolatopsis fastidiosa

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.86

21 January 2018

Discovery and antibacterial activity of lucensimycin C from Streptomyces lucensis

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.86

21 January 2018

Discovery of okilactomycin and congeners from Streptomyces scabrisporus by antisense differential sensitivity assay targeting ribosomal protein S4

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.86

21 January 2018

Isolation, Structure, and Absolute Stereochemistry of Platensimycin, A Broad Spectrum Antibiotic Discovered Using an Antisense Differential Sensitivity Strategy

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.86

21 January 2018

Isolation and Structure of Platencin: A FabH and FabF Dual Inhibitor with Potent Broad-Spectrum Antibiotic Activity

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.86

21 January 2018

Coniothyrione, a Chlorocyclopentandienylbenzopyrone as a Bacterial Protein Synthesis Inhibitor Discovered by Antisense Technology

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.86

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolation, structure and antibacterial activity of pleosporone from a pleosporalean ascomycete discovered by using antisense strategy

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.86

7 January 2021

based on heuristic

inferred from DOI database lookup

A Staphylococcus aureus fitness test platform for mechanism-based profiling of antibacterial compounds

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.86

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolation and structure of flutimide, a novel endonuclease inhibitor of influenza virus

25

1 reference

10.1038/JA.2010.86

https://api.crossref.org/works/10.1038/JA.2010.86

11 June 2024

Identifiers

10.1038/JA.2010.86

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42954882&oldid=2179000946"